Vascular Disorders
-
HI-PEITHO confirms benefit of USCDT in intermediate-risk pulmonary embolism
Investigator Frederikus A. Klok, MD, PhD, said he expects additional evidence to be published in the coming year, which will shape future guidelines and clinical management of patients with intermediate-high risk pulmonary embolism.
-
Catching decompensation earlier in acute pulmonary embolism
The 2026 AHA/ACC guidelines provide a much-needed physiological road map for the modern pulmonary embolism specialist with the introduction of new classification groups.
-
Data show OSA is an independent, modifiable risk factor for cerebral microbleeds
The first prospective, longitudinal study of OSA and cerebral microbleeds (CMBs) found that moderate to severe OSA more than doubles the risk for microbleeds.
-
Session addresses complex pulmonary vascular challenges in cirrhosis
Yu Kuang (Julie) Lai, MD, detailed the diagnosis of hepatopulmonary syndrome and post-liver transplant hypoxemia during the session, which also reviewed portopulmonary hypertension.
-
Session to discuss the management of pulmonary disease during pregnancy
Lisa K. Moores, MD, FCCP, will present during a Tuesday afternoon session on how physiology during pregnancy alters the clinical presentation and management of pulmonary disorders.
-
Experts to explore imaging modalities for the often-overlooked right heart
Navitha Ramesh, MD, MBBS, FCCP, will chair a session on available imaging techniques and considerations for evaluating the complex structure and function of the right ventricle.
